C
CANF
Can-Fite BioPharma Ltd.
0.66
-0.01-1.53%After Hours: 0.6510 -0.01 -1.62%19:19 08/15 EDT
OPEN/PREV CLOSE0.6700/0.6720
TODAY RANGE0.6500-0.6700
VOL79.00K
MARKET CAP9.64M
52 WEEK RANGE0.6320-3.120
AVG VOL (3M)179.26K
% TURNOVER0.54%
TURNOVER--
P/E (TTM)-0.6091
% RANGE2.98%
EPS(TTM)-1.0863
P/E(FORWARD)-1.2725
P/B1.211
BVPS0.5466
DIVIDEND--
P/S9.76
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.64M
SHARES OUTSTANDING14.57M
NEXT EARNINGS08/28-09/01
FREE FLOAT14.57M
LOT SIZE1
EX-DATE01/09/2023
News
Press Releases
Financial Reports
Profile
TipRanks·07/30 11:27
Can-Fite BioPharma Achieves Enrollment Milestone in Pancreatic Cancer Trial
TipRanks·07/30 11:25
Can-Fite achieved over 50% enrollment in Phase 2a trial of Namodenoson
TipRanks·07/29 14:19
Can-Fite BioPharma Raises $5 Million in Public Offering
Dow Jones·07/29 13:28
Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital
Benzinga·07/28 17:06
12 Health Care Stocks Moving In Monday's Intraday Session
TipRanks·07/28 16:40
Can-Fite BioPharma trading resumes
Reuters·07/28 16:24
CAN-FITE ANNOUNCES UP TO $15.0 MILLION PUBLIC OFFERING
TipRanks·07/28 16:15
Can-Fite BioPharma trading halted, news pending
TipRanks·07/28 11:27
Can-Fite BioPharma’s Piclidenoson Shows Promise in Vascular Dementia Treatment
TipRanks·07/28 11:16
Can-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
Same Industry
Name/Symbol
Change%
Price